Anti-MAG neuropathy is a demyelinating neuropathy mediated by a monoclonal IgM antibody that binds to MAG protein and, different from CIDP, is not considered an inflammatory disease, and therefore, typical CIDP treatments are usually only transiently effective in these patients. The gene discussed is MAG; the disease is neuropathy.